Epigenetic regulation of normal human mammary cell type-specific miRNAs

Genome Research

Volumn 21, Issue 12, 2011, Pages 2026-2037

  Vrba, Lukas ^a,b   Garbe, James C ^c   Stampfer, Martha R ^a,c   Futscher, Bernard W ^a,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b INSTITUTE OF PLANT MOLECULAR BIOLOGY   (Czech Republic)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; BREAST CELL; CELL DIFFERENTIATION; CELL SPECIFICITY; DNA METHYLATION; FIBROBLAST; GENE EXPRESSION; GENETIC EPIGENESIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TISSUE SPECIFICITY;

BREAST; CELL LINE; EPIGENESIS, GENETIC; FEMALE; FIBROBLASTS; HUMANS; MICRORNAS; ORGAN SPECIFICITY;

EID: 83055182019     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.123935.111     Document Type: Article

References (43)

1. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, et al. 2009. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219: 214-221.
2. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21. (Pubitemid 34049633)
3. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. 2006. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20: 1123-1136.
4. Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernandez-Piqueras J, Malumbres M. 2008. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506. (Pubitemid 351763902)
5. Epsztejn-Litman S, Feldman N, Abu-RemailehM, Shufaro Y, Gerson A, Ueda J, Deplus R, Fuks F, Shinkai Y, Cedar H, et al. 2008. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 15: 1176-1183.
6. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
7. Garbe JC, Bhattacharya S, Merchant B, Bassett E, Swisshelm K, Feiler HS, Wyrobek AJ, Stampfer MR. 2009. Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. Cancer Res 69: 7557-7568.
8. Gardiner-Garden M, Frommer M. 1987. CpG islands in vertebrate genomes. J Mol Biol 196: 261-282. (Pubitemid 17122132)
9. Gee HE, Camps C, Buffa FM, Colella S, Sheldon H, Gleadle JM, Ragoussis J, Harris AL. 2008. MicroRNA-10b and breast cancer metastasis. Nature 455: E8-E9.
10. Greene SB, Herschkowitz JI, Rosen JM. 2010. The ups and downs of miR- 205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol 7: 300-304.
11. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. 2008a. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601. (Pubitemid 351627379)
12. Gregory PA, Bracken CP, Bert AG, Goodall GJ. 2008b. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7: 3112-3118.
13. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88. (Pubitemid 47031323)
14. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, Edsall LE, Kuan S, Luu Y, Klugman S, et al. 2010. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6: 479-491.
15. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318. (Pubitemid 46328487)
16. Iorio MV, Casalini P, Piovan C,Di LevaG, Merlo A, Triulzi T, Menard S, Croce CM, Tagliabue E. 2009. microRNA-205 regulates HER3 in human breast cancer. Cancer Res 69: 2195-2200.
17. Iorio MV, Piovan C, Croce CM. 2010. Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta 1799: 694-701.
18. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33: 245-254. (Pubitemid 36278835)
19. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. 2008. Exploration of tumorsuppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105. (Pubitemid 351521781)
20. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, Low HM, Kin Sung KW, Rigoutsos I, Loring J, et al. 2010. Dynamic changes in the human methylome during differentiation. Genome Res 20: 320-331.
21. Liang G, Lin JC,Wei V, Yoo C, Cheng JC, Nguyen CT,Weisenberger DJ, Egger G, Takai D, Gonzales FA, et al. 2004. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc Natl Acad Sci 101: 7357-7362. (Pubitemid 38638037)
22. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. 2009. Human DNA methylomes at base resolution showwidespread epigenomic differences. Nature 462: 315-322.
23. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, et al. 2008. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci 105: 13556-13561.
24. Lund AH. 2010. miR-10 in development and cancer. Cell Death Differ 17: 209-214.
25. Ma L, Weinberg RA. 2008. MicroRNAs in malignant progression. Cell Cycle 7: 570-572. (Pubitemid 351498993)
26. MaL, Teruya-Feldstein J,Weinberg RA. 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688. (Pubitemid 47552092)
27. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, Johnston WK, Wernig M, Newman J, et al. 2008. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134: 521-533.
28. Miranda TB, Jones PA. 2007. DNA methylation: the nuts and bolts of repression. J Cell Physiol 213: 384-390. (Pubitemid 47509717)
29. Novak P, Jensen TJ, Garbe JC, Stampfer MR, Futscher BW. 2009. Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. Cancer Res 69: 5251-5258.
30. Oshiro MM,Watts GS,Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW. 2003. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 22: 3624-3634. (Pubitemid 36765322)
31. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS, Fisher DE. 2008. Chromatin structure analyses identify miRNA promoters. Genes Dev 22: 3172-3183.
32. Park SM, Gaur AB, Lengyel E, Peter ME. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907. (Pubitemid 351482843)
33. Peter ME. 2009. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8: 843-852.
34. R-Development-Core-Team. 2011. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria.
35. Rauch T,Wang Z, Zhang X, Zhong X,Wu X, Lau SK, Kernstine KH, Riggs AD, Pfeifer GP. 2007. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci 104: 5527-5532. (Pubitemid 47175714)
36. Simon JA, Kingston RE. 2009. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10: 697-708.
37. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H, et al. 2002. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16: 1779-1791. (Pubitemid 34803894)
38. Tellez CS, Juri DE, Do K, Bernauer AM, Thomas CL, Damiani LA, Tessema M, Leng S, Belinsky SA. 2011. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res 71: 3087-3097.
39. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z. 2010. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 285: 7986-7994.
40. Vrba L, Junk DJ, Novak P, FutscherBW. 2008. p53 induces distinct epigenetic states at its direct target promoters. BMC Genomics 9: 486. doi: 10.1186/ 1471-2164-9-486.
41. Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, Dickinson S, Stampfer MR, Futscher BW. 2010. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS ONE 5: e8697. doi: 10.1371/journal.pone.0008697.
42. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. 2005. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862. (Pubitemid 41077111)
43. Wu H, Coskun V, Tao J, Xie W, Ge W, Yoshikawa K, Li E, Zhang Y, Sun YE. 2010. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 329: 444-448.